WUXI VACCINES
DEAD

Serial Number

79331219

Owner

Shanghai Vaccines Co., Ltd.

Attorney

Eric Lamb

Filing Date

Jul 20, 2021

Add to watchlist:

No watchlists yet
View on USPTO

WUXI VACCINES Trademark

Serial Number: 79331219

WUXI VACCINES is a trademark filed by Shanghai Vaccines Co., Ltd. on July 20, 2021. The trademark is classified under Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Shanghai Vaccines Co., Ltd. (3 trademarks)

Room 502A, 5th Floor,

Entity Type: 16

Trademark Details

Filing Date

July 20, 2021

Registration Date

Not Registered

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Dec 26, 2023 FINT
FINAL DISPOSITION NOTICE SENT TO IB
Dec 6, 2023 FICS
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Dec 6, 2023 FICR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jul 3, 2023 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jun 15, 2023 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jun 14, 2023 OPNR
ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Dec 6, 2022 MAB2
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Dec 6, 2022 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Dec 6, 2022 ABN2
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Sep 30, 2022 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 30, 2022 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 30, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 30, 2022 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Sep 30, 2022 COAR
REFUSAL PROCESSED BY IB
Jun 13, 2022 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
May 24, 2022 RFCS
REFUSAL PROCESSED BY MPU
May 24, 2022 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 15, 2022 RFCR
NON-FINAL ACTION WRITTEN
Apr 14, 2022 CNRT
ASSIGNED TO EXAMINER
Apr 13, 2022 DOCK
APPLICATION FILING RECEIPT MAILED
Jan 22, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 18, 2022 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jan 13, 2022 REPR